New blood pressure drug enters first human testing
NCT ID NCT06823947
Summary
This is an early safety study testing a new experimental drug called KK3910 for high blood pressure. Researchers will first give single doses to healthy volunteers, then multiple doses to patients with high blood pressure to check for side effects. The study will also measure how the drug moves through the body to determine safe dosage levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS ESSENTIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kitasato University Kitasato Institute Hospital
RECRUITINGMinato-ku, Tokyo, 108-8642, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medical Corporation Heishinkai OPHAC Hospital
NOT_YET_RECRUITINGYodogawa, Osaka, 532-0003, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SOUSEIKAI PS Clinic
NOT_YET_RECRUITINGHakata, Fukuoka, 812-0025, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.